focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe dares to reopen as 200 millionth vaccine dose delivered

Mon, 10th May 2021 13:41

By Michael Gore and Estelle Shirbon

MADRID/LONDON, May 10 (Reuters) - As its vaccination drive
reaches a third of adults and COVID-19 infections ease, Europe
is starting to reopen cities and beaches, raising hopes that
this summer's holiday season can be saved before it is too late.

Exhilarated Spaniards chanting "freedom" danced in the
streets as a COVID-19 curfew ended in most of the country at the
weekend, while Greece reopened public beaches - with deckchairs
safely spaced.

With 200 million vaccine doses delivered, the European Union
is on track to achieve its goal of inoculating 70% of its adult
population by summer, Commission President Ursula von der Leyen
tweeted on Sunday.

And, in Germany, a first weekend of summer sun lifted
spirits after Health Minister Jens Spahn declared the third wave
of the pandemic finally broken.

Yet, Spahn warned: "The mood is better than the reality."

The national seven-day incidence of COVID-19 cases remains
high at 119 per 100,000 people, he said. "That makes it all the
more important to keep up the speed of the vaccination
campaign."

Across the EU, the seven-day incidence of COVID-19 is 185,
according to Our World in Data. That is far higher than in
countries such as Israel with 6, Britain (31), or the United
States (123), all of which made quicker early progress in their
vaccination drives.

HEAD START

In Britain, early orders and approval of vaccines and a
decision to give first doses to as many people as possible have
driven down infections and fatalities far more quickly.

Prime Minister Boris Johnson was expected to set out the
next phase of lockdown easing in England, giving the green light
to "cautious hugging" and allowing pubs to serve customers pints
inside after months of strict measures.

"The data reflects what we already knew - we are not going
to let this virus beat us," Johnson said ahead of an official
announcement later on Monday.

Vaccine deliveries were slower initially in the EU under its
centralised procurement strategy.

Now, with shots from BioNTech/Pfizer and Moderna relatively
plentiful, vaccinations as a share of the population in Europe
are growing while countries that made early advances see
slowdowns as they encounter hesitancy among the unvaccinated.

Some 31.6% of adults in 30 European countries have received
a first dose and 12% a full two-shot regime, the European Centre
for Disease Prevention and Control's COVID-19 Vaccine Tracker https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
showed.

France expects to give 20 million first injections by
mid-May, and hit 30 million by mid-June.

With infection rates falling and occupancy in hospital
intensive care units declining, France plans to start relaxing
its curfew and allow cafes, bars and restaurants to offer
outdoor service from May 19.

PICKING AND CHOOSING

Improving supply has given countries greater freedom to
adapt their strategies following reports of very rare, but
sometimes fatal, blood clotting in people who received shots
from AstraZeneca and Johnson & Johnson.

Germany has decided to make the two vaccines available to
anyone who wants them, as long as they have been advised by a
doctor - an offer aimed at younger adults who would have to wait
their turn otherwise.

Norway's vaccine commission made a similar call on Monday,
saying the AstraZeneca and J&J shots should be made available to
volunteers. Some Italian regions are also offering both shots to
people under 60.

With some governments shortening the gaps between doses, and
plans for an EU digital "green pass" scheme in June for
travellers to provide proof of vaccination or immunity, people
cooped up for months are finally daring to make holiday plans.

"We're pinning our hopes on tourism," said Nikos Venieris,
who manages a beach in Alimos, an Athens suburb.

Tourism accounts for about a fifth of Greece's economy and
jobs, and the country can ill afford another lost summer. Greece
is lifting restrictions on vaccinated foreigners from May 15.

(Writing by Douglas Busvine
Additional reporting by Jordi Rubio, Terje Solsvik, Gwladys
Fouche, Matthias Blamont, Emilio Parodi, John Miller, Alan
Charlish and Phoebe Fronista
Editing by Giles Elgood)

More News
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.